Menu

New Zika Transmission Zone Near Miami

The US Centers for Disease Control and Prevention identifies a 1-square-mile area near Miami where Zika virus appears to be spreading.

Oct 14, 2016
Ben Andrew Henry

WIKIPEDIA, JAMES GATHANY

The US Centers for Disease Control and Prevention (CDC) on Thursday (October 13) announced that Zika virus has been found actively spreading in an area near Miami, where health officials confirmed five new cases of infection.

Weeks earlier, the nearby Wynwood neighborhood was cleared of the virus, but a section of Miami Beach remains an area of active transmission. The CDC reiterated its advice that pregnant women consider avoiding travel to Miami-Dade County.

The newly identified zone occupies about one square mile to the north of Miami. Three of the new cases are in individuals who live in the area, while the other two individuals work or visit the area. Around 1,020 Zika cases have been identified in Florida, STAT News reported, but the majority of those cases are in individuals who caught the virus travelling outside the country. 

The onset of cooler weather should help lower the risk of mosquito-borne transmission, but “we’re not yet at the end of mosquito season, so we might continue to see local transmission going on for a little while yet,” Tom Skinner, a spokesperson for the CDC, told STAT News.

“We have seen that aggressive mosquito control efforts have worked in areas like Wynwood and we hope the county also aggressively sprays in this area,” Florida Governer Rick Scott said in a statement.

Scott stressed the need to mobilize government resources for keeping Zika under control. “It has been two weeks since federal funding to fight Zika was approved by Congress and signed by President Obama. However, Florida has not yet received a dime. We don’t need bureaucratic timelines—we need funding now.” 

See “Congress Approves $1.1 Billion for Zika

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.